These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 20364755)

  • 21. Successful treatment of methicillin-resistant Staphylococcus aureus endocarditis with linezolid.
    Bassetti M; Di Biagio A; Del Bono V; Cenderello G; Bassetti D
    Int J Antimicrob Agents; 2004 Jul; 24(1):83-4. PubMed ID: 15225867
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Oxazolidinones--a new class of broad-spectrum chemotherapeutics.
    Sztanke K; Pasternak K; Sztanke M
    Ann Univ Mariae Curie Sklodowska Med; 2004; 59(2):335-41. PubMed ID: 16146103
    [TBL] [Abstract][Full Text] [Related]  

  • 23. In vivo efficacy of linezolid in combination with gentamicin for the treatment of experimental endocarditis due to methicillin-resistant Staphylococcus aureus.
    Jacqueline C; Asseray N; Batard E; Le Mabecque V; Kergueris MF; Dube L; Bugnon D; Potel G; Caillon J
    Int J Antimicrob Agents; 2004 Oct; 24(4):393-6. PubMed ID: 15380267
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Resistance or decreased susceptibility to glycopeptides, daptomycin, and linezolid in methicillin-resistant Staphylococcus aureus.
    Nannini E; Murray BE; Arias CA
    Curr Opin Pharmacol; 2010 Oct; 10(5):516-21. PubMed ID: 20598637
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Linezolid resistance in sequential Staphylococcus aureus isolates associated with a T2500A mutation in the 23S rRNA gene and loss of a single copy of rRNA.
    Meka VG; Pillai SK; Sakoulas G; Wennersten C; Venkataraman L; DeGirolami PC; Eliopoulos GM; Moellering RC; Gold HS
    J Infect Dis; 2004 Jul; 190(2):311-7. PubMed ID: 15216466
    [TBL] [Abstract][Full Text] [Related]  

  • 26. In vitro activity of fosfomycin in combination with linezolid against clinical isolates of methicillin-resistant Staphylococcus aureus.
    Xu-hong Y; Falagas ME; Dong W; Karageorgopoulos DE; De-feng L; Rui W
    J Antibiot (Tokyo); 2014 May; 67(5):369-71. PubMed ID: 24517925
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Glycopeptide insensitive Staphylococcus aureus subdural empyema treated with linezolid and rifampicin.
    Gallagher RM; Pizer B; Ellison JA; Riordan FA
    J Infect; 2008 Nov; 57(5):410-3. PubMed ID: 18703232
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Linezolid tissue penetration and serum activity against strains of methicillin-resistant Staphylococcus aureus with reduced vancomycin susceptibility in diabetic patients with foot infections.
    Stein GE; Schooley S; Peloquin CA; Missavage A; Havlichek DH
    J Antimicrob Chemother; 2007 Oct; 60(4):819-23. PubMed ID: 17673476
    [TBL] [Abstract][Full Text] [Related]  

  • 29. In-vitro activity of linezolid against clinical isolates of Gram-positive cocci in a tertiary care hospital.
    Navaneeth BV; Belwadi SM; Indumathi VA; Gayathri DD
    J Assoc Physicians India; 2004 May; 52():429-30. PubMed ID: 15656039
    [No Abstract]   [Full Text] [Related]  

  • 30. Relationship of linezolid minimum inhibitory concentration and time to bacterial eradication in treatment for methicillin-resistant Staphylococcus aureus infection.
    Moise PA; Castro RS; Sul C; Forrest A; Sakoulas G
    Ann Pharmacother; 2008 Apr; 42(4):592-3. PubMed ID: 18349303
    [No Abstract]   [Full Text] [Related]  

  • 31. Use of linezolid, an oxazolidinone, in the treatment of multidrug-resistant gram-positive bacterial infections.
    Chien JW; Kucia ML; Salata RA
    Clin Infect Dis; 2000 Jan; 30(1):146-51. PubMed ID: 10619743
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Linezolid--novel antibiotic for the treatment of gram-positive bacterial infections].
    Jankowski A; Stefanik W
    Wiad Lek; 2006; 59(9-10):727-31. PubMed ID: 17338140
    [TBL] [Abstract][Full Text] [Related]  

  • 33. In vitro activity of linezolid against Staphylococcus aureus: a population study.
    Rodríguez JC; Ethlvarez JM; Escribano I; Royo G
    Chemotherapy; 2005 May; 51(2-3):86-8. PubMed ID: 15886467
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Linezolid and quinupristin/dalfopristin resistance in vancomycin-resistant enterococci and methicillin-resistant Staphylococcus aureus prior to clinical use in Turkey.
    Baysallar M; Kilic A; Aydogan H; Cilli F; Doganci L
    Int J Antimicrob Agents; 2004 May; 23(5):510-2. PubMed ID: 15120733
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Trends in linezolid susceptibility patterns in 2002: report from the worldwide Zyvox Annual Appraisal of Potency and Spectrum Program.
    Ross JE; Anderegg TR; Sader HS; Fritsche TR; Jones RN
    Diagn Microbiol Infect Dis; 2005 May; 52(1):53-8. PubMed ID: 15878443
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Linezolid alone and in combination with rifampicin prevents experimental vascular graft infection due to methicillin-resistant Staphylococcus aureus and Staphylococcus epidermidis.
    Sacar M; Sacar S; Kaleli I; Onem G; Turgut H; Goksin I; Ozcan V; Kaan Inan B; Duver H; Baltalarli A
    J Surg Res; 2007 May; 139(2):170-5. PubMed ID: 17292421
    [TBL] [Abstract][Full Text] [Related]  

  • 37. In vitro evaluation of ceftaroline alone and in combination with tobramycin against hospital-acquired meticillin-resistant Staphylococcus aureus (HA-MRSA) isolates.
    Vidaillac C; Leonard SN; Rybak MJ
    Int J Antimicrob Agents; 2010 Jun; 35(6):527-30. PubMed ID: 20346632
    [TBL] [Abstract][Full Text] [Related]  

  • 38. In vitro activity of linezolid alone and in combination with gentamicin, vancomycin or rifampicin against methicillin-resistant Staphylococcus aureus by time-kill curve methods.
    Jacqueline C; Caillon J; Le Mabecque V; Miegeville AF; Donnio PY; Bugnon D; Potel G
    J Antimicrob Chemother; 2003 Apr; 51(4):857-64. PubMed ID: 12654769
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [In vitro activity of linezolid against clinical isolates of methicillin-resistant Staphylococcus aureus].
    Pérez L; Alarcón T; Jiménez S; de Las Cuevas MC; López-Brea S
    Rev Esp Quimioter; 2001 Mar; 14(1):47-50. PubMed ID: 11376349
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Efficacy and pharmacodynamics of linezolid, alone and in combination with rifampicin, in an experimental model of methicillin-resistant Staphylococcus aureus endocarditis.
    Tsaganos T; Skiadas I; Koutoukas P; Adamis T; Baxevanos N; Tzepi I; Pelekanou A; Giamarellos-Bourboulis EJ; Giamarellou H; Kanellakopoulou K
    J Antimicrob Chemother; 2008 Aug; 62(2):381-3. PubMed ID: 18445576
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.